Malaria Consortium is delighted to announce the appointment of Professor Marcel Tanner as Chair of the Board of Trustees. His appointment comes following a transition from the previous Chair, Dr. Julian Lob-Levyt, who steps down after six years, following the completion of his tenure in the role.
Malaria Consortium would like to take this opportunity to thank Dr. Lob-Levyt for his commitment as Chair and to recognise his excellent efforts in leading the Board and furthering the work and achievements of Malaria Consortium.
On handing over to Professor Tanner, Dr. Lob-Levyt commented: “It has been a privilege to serve as Chair of the Malaria Consortium these past six years. I would like to thank not only my fellow trustees (past and present) but also all the superb staff that have made the Malaria Consortium what it is today, a strong and highly thought of international organisation committed to supporting the health of people in some of the poorest parts of the world. I also thank our many and diverse donors and supporters. I am thrilled that Professor Tanner accepted to become Chair and wish him as much pleasure and pride as I have had the good fortune to enjoy in this remarkable organisation.”
Professor Marcel Tanner is the former director of the Swiss Tropical and Public Health Institute and professor of epidemiology and medical parasitology at the University of Basel. He has devoted his entire life to the development of new drugs and vaccines for the eradication of malaria and other poverty-related diseases and to find new solutions to strengthen health systems in Africa and the Pacific region.
In addition to his role with Malaria Consortium, Professor Tanner was a member of the Malaria Policy Advisory Committee (MPAC) of WHO until this year and is chair of the Strategic Advisory Group (SAG) of GMP/WHO, and chair of the INCLEN Trust, the INDEPTH network and of the Drugs for Neglected Diseases initiative (DNDi). He chairs the Scientific Advisory Board of FIND and is a member of the Scientific Advisory Board of the Novartis Institute for Tropical Diseases in Singapore. Professor Tanner was key in building up research and implementation institutions in Africa, namely the Ifakara Health Institute (IHI) in Tanzania and the Centre Suisse de Recherche Scientifiques (CSRS) in Côte d’Ivoire.
“It is a pleasure and great privilege to follow Dr. Julian Lob-Levyt as chair and to assist the further development of the Malaria Consortium and further strengthen its impact for those most in need,” said Professor Tanner, commenting on his appointment.
Malaria Consortium looks forward to working with Professor Tanner in our next chapter, and to continuing to pursue across the organisation the technical excellence and reputable evidence-based solutions for which we are renowned.